Novo Nordisk A/S announced the launch of the insulin delivery device NovoPen Echo(R) in the United States. This is the first and only pen device available in the U.S. with half-unit dosing and a memory function that records the dose and time passed since the last injection. Half-unit dose increments allow for finer adjustments, which can be particularly important for children.

In addition, 12 fun removable skins are available for a customized look, including kid-friendly designs. This pen is the latest insulin delivery system offered from Novo Nordisk, and is available to patients for use with NovoLog(R) PenFill(R) cartridges.